FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224078489> ?p ?o ?g. }

• W4224078489 endingPage "105528" @default.
• W4224078489 startingPage "105528" @default.
• W4224078489 abstract "Genital mycoplasma are only considered pathogenic at a certain level and are often associated with other pathological situations such as bacterial vaginosis (BV). They may lead to infertility as well as other gynaeco-obstetrical and neonatal problems. Despite numerous reported resistances, macrolides are required to treat pregnant women while non-pregnant women are managed with tetracyclines and fluoroquinolones. This study aimed to establish the prevalence and resistance rates of Mycoplasma hominis (Mh) and Ureaplasma spp. (Uu) in BV positive (BV+) women.Vaginal secretions were collected from women aged 14-56 years consulting for a cytobacteriological examination of the vaginal swab associated with a simultaneous search for genital mycoplasma in the medical analysis laboratory of the Research and Medical Analysis Unit (URAM) of CIRMF in Franceville, Gabon. BV was diagnosed using the Nugent score while genital mycoplasma identification and antibiotic susceptibility testing were performed using the Mycoplasma IST 2 kit.Of the 462 women included in this study, 60.18% (278/462, p = 0.00002) were both BV+ and genital mycoplasma carriers, including 5.19% (24/462) pregnant women. Overall mycoplasma carriage was 33.12% (153/462) for Uu, 1.95% for Mh and 25.11% (116/462) for mixed infections (Uu + Mh). The BV + patients most affected by mycoplasma were those whose age varied from 25 to 35 years with 27.49% (127/462, p = 0.980), those not using condoms with 39.40% (182/462, p = 0.014, OR = 2.35), those non-pregnant but capable of bearing children with 53.90% (249/462, p = 0.967, OR = 1.02). In the overall population, 83.66% and 51.63% of Uu strains were highly resistant to Ciprofloxacin and Azithromycin respectively; 100% and 55.56% of Mh strains were resistant to Azithromycin and Tetracycline respectively; while strong resistance has been observed in mixed infections to Ciprofloxacin (97.41%), Azithromycin (81.90%), Ofloxacin (69.83%) and Tetracycline (68.97%).The prevalence of genital mycoplasma infections is very high in women with bacterial vaginosis. Given the numerous emerging resistance rates to most classes of antibiotics available for the treatment of genital mycoplasma infections in our study, it would be advisable for therapeutic prescriptions to be made based on laboratory results." @default.
• W4224078489 created "2022-04-19" @default.
• W4224078489 creator A5013925356 @default.
• W4224078489 creator A5029227346 @default.
• W4224078489 creator A5040852649 @default.
• W4224078489 creator A5083527699 @default.
• W4224078489 date "2022-05-01" @default.
• W4224078489 modified "2023-09-27" @default.
• W4224078489 title "Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon" @default.
• W4224078489 cites W1949284874 @default.
• W4224078489 cites W1975416947 @default.
• W4224078489 cites W1984358627 @default.
• W4224078489 cites W1998475729 @default.
• W4224078489 cites W2007711540 @default.
• W4224078489 cites W2069595629 @default.
• W4224078489 cites W2074173582 @default.
• W4224078489 cites W2102885994 @default.
• W4224078489 cites W2103847234 @default.
• W4224078489 cites W2107450223 @default.
• W4224078489 cites W2108913174 @default.
• W4224078489 cites W2165565002 @default.
• W4224078489 cites W2166542861 @default.
• W4224078489 cites W2171959793 @default.
• W4224078489 cites W2212096187 @default.
• W4224078489 cites W2323464715 @default.
• W4224078489 cites W2411057177 @default.
• W4224078489 cites W2545254289 @default.
• W4224078489 cites W2728306113 @default.
• W4224078489 cites W2753183473 @default.
• W4224078489 cites W2766724032 @default.
• W4224078489 cites W2777905144 @default.
• W4224078489 cites W2783722756 @default.
• W4224078489 cites W2796688137 @default.
• W4224078489 cites W2895359673 @default.
• W4224078489 cites W2972724003 @default.
• W4224078489 cites W3013774801 @default.
• W4224078489 cites W3023262106 @default.
• W4224078489 cites W3036841422 @default.
• W4224078489 cites W3094066492 @default.
• W4224078489 cites W3128580337 @default.
• W4224078489 cites W4236786088 @default.
• W4224078489 doi "https://doi.org/10.1016/j.micpath.2022.105528" @default.
• W4224078489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35430268" @default.
• W4224078489 hasPublicationYear "2022" @default.
• W4224078489 type Work @default.
• W4224078489 citedByCount "1" @default.
• W4224078489 countsByYear W42240784892022 @default.
• W4224078489 crossrefType "journal-article" @default.
• W4224078489 hasAuthorship W4224078489A5013925356 @default.
• W4224078489 hasAuthorship W4224078489A5029227346 @default.
• W4224078489 hasAuthorship W4224078489A5040852649 @default.
• W4224078489 hasAuthorship W4224078489A5083527699 @default.
• W4224078489 hasConcept C131872663 @default.
• W4224078489 hasConcept C183021626 @default.
• W4224078489 hasConcept C2776672898 @default.
• W4224078489 hasConcept C2777688143 @default.
• W4224078489 hasConcept C2777831542 @default.
• W4224078489 hasConcept C2778838687 @default.
• W4224078489 hasConcept C2779186046 @default.
• W4224078489 hasConcept C2779234561 @default.
• W4224078489 hasConcept C2779952448 @default.
• W4224078489 hasConcept C2909217659 @default.
• W4224078489 hasConcept C29456083 @default.
• W4224078489 hasConcept C501593827 @default.
• W4224078489 hasConcept C54355233 @default.
• W4224078489 hasConcept C71924100 @default.
• W4224078489 hasConcept C86803240 @default.
• W4224078489 hasConcept C89423630 @default.
• W4224078489 hasConceptScore W4224078489C131872663 @default.
• W4224078489 hasConceptScore W4224078489C183021626 @default.
• W4224078489 hasConceptScore W4224078489C2776672898 @default.
• W4224078489 hasConceptScore W4224078489C2777688143 @default.
• W4224078489 hasConceptScore W4224078489C2777831542 @default.
• W4224078489 hasConceptScore W4224078489C2778838687 @default.
• W4224078489 hasConceptScore W4224078489C2779186046 @default.
• W4224078489 hasConceptScore W4224078489C2779234561 @default.
• W4224078489 hasConceptScore W4224078489C2779952448 @default.
• W4224078489 hasConceptScore W4224078489C2909217659 @default.
• W4224078489 hasConceptScore W4224078489C29456083 @default.
• W4224078489 hasConceptScore W4224078489C501593827 @default.
• W4224078489 hasConceptScore W4224078489C54355233 @default.
• W4224078489 hasConceptScore W4224078489C71924100 @default.
• W4224078489 hasConceptScore W4224078489C86803240 @default.
• W4224078489 hasConceptScore W4224078489C89423630 @default.
• W4224078489 hasLocation W42240784891 @default.
• W4224078489 hasLocation W42240784892 @default.
• W4224078489 hasOpenAccess W4224078489 @default.
• W4224078489 hasPrimaryLocation W42240784891 @default.
• W4224078489 hasRelatedWork W2014062653 @default.
• W4224078489 hasRelatedWork W2355811465 @default.
• W4224078489 hasRelatedWork W2380619256 @default.
• W4224078489 hasRelatedWork W2895359673 @default.
• W4224078489 hasRelatedWork W4206907691 @default.
• W4224078489 hasRelatedWork W4221047295 @default.
• W4224078489 hasRelatedWork W4224078489 @default.
• W4224078489 hasRelatedWork W4233167046 @default.
• W4224078489 hasRelatedWork W59554899 @default.
• W4224078489 hasRelatedWork W2263360811 @default.

• next